Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.
Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference5%
- Check36 days agoChange DetectedSeveral key health-related URLs have been removed, including those related to genetics, melanoma, and rare diseases, which may impact access to important medical information.SummaryDifference0.7%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new resources added, including links to genetics information, melanoma details, and clinical trial data, while the previous version 2.12.1 has been removed.SummaryDifference6%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.